Use of Interferon-α for Prevention of Hepatocellular Carcinoma in Patients with Chronic Active Hepatitis C with Cirrhosis
Hepatitis C virus (HCV) is a more important factor associated with hepatocellular carcinoma than hepatitis B virus (HBV) in Japan and certain Western countries [1–3]. Some patients who contracted chronic non-A, non-B hepatitis after blood transfusion and hepatocellular carcinoma many years later have been studied in detail [4–6]. These studies proved that patients with chronic HCV infection often develop hepatocellular carcinoma . The cumulative incidence of hepatocellular carcinoma in patients who had blood transfusions and were negative for hepatitis B surface antigen (HBsAg) was 53% (13/26) during 6 years of observation . All of these patients had HCV antibodies. The mechanism by which hepatocellular carcinoma develops in the presence of HCV is unknown.
KeywordsHepatocellular Carcinoma Serum Albumin Level Chronic Active Hepatitis Histological Activity Index
Unable to display preview. Download preview PDF.
- 15.Sherlock S, Dooley J (1997) Diseases of the liver and biliary system, 9th edn. Blackwell, Oxford, p 367Google Scholar
- 18.Okamoto H, Tokita H, Sakamoto M, et al (1993) Characterization of the genomic sequence of type V (or 3a) hepatic C virus isolates and PCR primers for specific detection. J Gen Virol 74:2835–2890Google Scholar